Cargando…
Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity
Although the majority of cancers respond to chemotherapy, most cancer types relapse, at least in part, due to the poor immunogenicity of most tumor. We have reported before that treatment of tumor bearing mice with a combination of the anti-cancer chemotherapy cyclophosphamide (CTX) and immunotherap...
Autores principales: | Salem, Mohamed L, El-Naggar, Sabry A, Mahmoud, Heba A, Elgharabawy, Rehab M, Bader, Abeer M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168726/ https://www.ncbi.nlm.nih.gov/pubmed/30270681 http://dx.doi.org/10.1177/2058738418796591 |
Ejemplares similares
-
The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice
por: Salem, Mohamed L., et al.
Publicado: (2020) -
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects
por: Patterson, Michael T., et al.
Publicado: (2023) -
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes
Publicado: (1981) -
Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8(+) T-cell responses and immune memory
por: Wu, Junjie, et al.
Publicado: (2015) -
Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms
por: Sedlik, Christine, et al.
Publicado: (2014)